A not for profit organisation

Request an appointment
Intravitreal dexamethasone versus bevacizumab in Aboriginal patients with Diabetic Macular Edema. (The OASIS Study)

Intravitreal dexamethasone versus bevacizumab in Aboriginal patients with Diabetic Macular Edema. (The OASIS Study)

Home Research Clinical Trial Intravitreal dexamethasone versus bevacizumab in Aboriginal patients with Diabetic Macular Edema. (The OASIS Study)

Phase IV Multicentre Randomised Clinical Trial of intravitreal bevacizumab 1.25mg versus dexamethasone 0.7mg for diabetic macular oedema in Aboriginal adults.

OASIS_Protocol

Trial Registry Number: NCT04619303

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Phone
(08) 9381 0777
Email
carecentre@staging.lei.org.au

Request an appointment